IASR Vol.17 No.3 March 1996 (No.193)
–³‹Û«‘–Œ‰Š‚ÆŠÖ˜AƒEƒCƒ‹ƒX‚Ì“®Œü@1995
–ÚŽŸ
- ƒGƒR[ƒEƒCƒ‹ƒX‚VŒ^‚Ì—¬sF’¹ŽæŒ§
- 1995”N‚̃€ƒ“ƒvƒXƒEƒCƒ‹ƒXŒŸoó‹µFH“cŒ§
- AŒ^ŠÌ‰Š‚ÌW’c”¶Fç—tŽs
- fluoroquinolone‘Ï«Ô—Ÿ‘“à—á
- HIVŠ´õó‹µi1995”N––Œ»ÝjF“ú–{
- ŒŒ‰t»Ü‚É‚æ‚éAŒ^ŠÌ‰ŠF•Ä‘
- Š³ŽÒ‚Æ‹ŸŒŒŽÒ‚ÌHCV‚̈â“`ŽqŒ^FƒJƒiƒ_
- –ƒ]E•—]F‰p‘
- ¬Ž™‚̃ƒNƒ`ƒ“ÚŽí—¦F•Ä‘
- —\–hÚŽíƒXƒPƒWƒ…[ƒ‹Fƒˆ[ƒƒbƒp
- ’j«–ò•¨í’ŽÒ‚ÌHIVŠ´õƒŠƒXƒNsˆ×F•Ä‘
- Œ‹Šj‚ÆAIDS“¯ŽžœëŠ³—¦F•Ä‘
- ‘–Œ‰Š‹Û«‘–Œ‰ŠF‰p‘
- “Å‘f”ñŽY¶«ƒWƒtƒeƒŠƒA‹ÛŠ´õF‰p‘
Return to the IASR HomePage
Return to the IASR HomePage(English)
ƒz[ƒ€‚Ö–ß‚é